Unknown

Dataset Information

0

The ATP-binding cassette transporter A1 regulates phosphoantigen release and V?9V?2 T cell activation by dendritic cells.

ABSTRACT: V?9V?2 T cells are activated by phosphoantigens, such as isopentenyl pyrophosphate (IPP), which is generated in the mevalonate pathway of antigen-presenting cells. IPP is released in the extracellular microenvironment via unknown mechanisms. Here we show that the ATP-binding cassette transporter A1 (ABCA1) mediates extracellular IPP release from dendritic cells (DC) in cooperation with apolipoprotein A-I (apoA-I) and butyrophilin-3A1. IPP concentrations in the supernatants are sufficient to induce V?9V?2 T cell proliferation after DC mevalonate pathway inhibition with zoledronic acid (ZA). ZA treatment increases ABCA1 and apoA-I expression via IPP-dependent LXR? nuclear translocation and PI3K/Akt/mTOR pathway inhibition. These results close the mechanistic gap in our understanding of extracellular IPP release from DC and provide a framework to fine-tune V?9V?2 T cell activation via mevalonate and PI3K/Akt/mTOR pathway modulation.

SUBMITTER: Castella B 

PROVIDER: S-EPMC5465356 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells.

Castella Barbara B   Kopecka Joanna J   Sciancalepore Patrizia P   Mandili Giorgia G   Foglietta Myriam M   Mitro Nico N   Caruso Donatella D   Novelli Francesco F   Riganti Chiara C   Massaia Massimo M  

Nature communications 20170605

Vγ9Vδ2 T cells are activated by phosphoantigens, such as isopentenyl pyrophosphate (IPP), which is generated in the mevalonate pathway of antigen-presenting cells. IPP is released in the extracellular microenvironment via unknown mechanisms. Here we show that the ATP-binding cassette transporter A1 (ABCA1) mediates extracellular IPP release from dendritic cells (DC) in cooperation with apolipoprotein A-I (apoA-I) and butyrophilin-3A1. IPP concentrations in the supernatants are sufficient to indu  ...[more]

Similar Datasets

Unknown MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1.
| S-EPMC3298756 | biostudies-literature
Unknown Small GTPase ARF6 Regulates Endocytic Pathway Leading to Degradation of ATP-Binding Cassette Transporter A1.
| S-EPMC5123748 | biostudies-literature
Unknown The phosphatase activity of soluble epoxide hydrolase regulates ATP-binding cassette transporter-A1-dependent cholesterol efflux.
| S-EPMC6787517 | biostudies-literature
Unknown MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor.
| S-EPMC3995747 | biostudies-literature
Unknown The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration.
| S-EPMC3712769 | biostudies-literature
Unknown Binding of PDZ-RhoGEF to ATP-binding cassette transporter A1 (ABCA1) induces cholesterol efflux through RhoA activation and prevention of transporter degradation.
| S-EPMC2871504 | biostudies-literature
Unknown Targeted Deletion of Adipocyte Abca1 (ATP-Binding Cassette Transporter A1) Impairs Diet-Induced Obesity.
| S-EPMC5864538 | biostudies-literature
Unknown Adipose tissue ATP binding cassette transporter A1 contributes to high-density lipoprotein biogenesis in vivo.
| S-EPMC3202242 | biostudies-literature
Unknown ATP Binding Cassette Transporter A1 is Involved in Extracellular Secretion of Acetylated APE1/Ref-1.
| S-EPMC6651529 | biostudies-literature
Unknown ATP-binding cassette transporter A1 gene polymorphisms and serum lipid levels in young Greek nurses.
| S-EPMC3090361 | biostudies-literature